CPS1 has been demonstrated to be downregulated in hepatocellular carcinoma by hypermethylation of the CPS1 promoter [14,15], whereas CAD mRNA levels were increased in HCC tissue [15]. The gene discussed is CPS1; the disease is hepatocellular carcinoma.